¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ƽ"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
Y45.4
Antirheumatics
Ç×·ù¸¶Æ¼½ºÁ¦
Y49.4
Butyrophenone and thioxanthene neuroleptics
ºÎƼ·ÎÆä³í ¹× Áö¿Á»êƾ ½Å°æÀÌ¿ÏÁ¦
Y54.0
Mineralocorticoid
¹Ì³×¶ö·ÎÄÚÆ¼ÄÚÀ̵å
Y54.1
Mineralocorticoid antagonists [aldosterone antagonists]
¹Ì³×¶ö·ÎÄÚÆ¼ÄÚÀÌµå ´ëÇ×Á¦(±æÇ×Á¦)[¾Ëµµ½ºÅ×·Ð ´ëÇ×Á¦(±æÇ×Á¦)]
Y54.3
Benzothiadiazine derivatives
º¥Á¶Æ¼¾Æµð¾ÆÁø À¯µµÃ¼
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½